Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune complex mediated activation of the classical complement pathway.

T Borsos1

  • 1Department of Pathology, Uniformed Services University of the Health Sciences, Bethesda MD 20814-4799.

Behring Institute Mitteilungen
|July 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of particulate number concentrations in three Central European capital cities.

The Science of the total environment·2012
Same author

Heat-labile, complement-like factor(s) of animal sera prevent(s) HIV-1 infectivity in vitro.

Journal of acquired immune deficiency syndromes·1990
Same author

Histories and mysteries about C1.

Behring Institute Mitteilungen·1989
Same author

Further evidence for dilution-dependent dissociation of C1q in human serum.

Complement and inflammation·1989
Same author

Activation of human C1r: Western blot analysis reveals slow and dose-dependent activation.

Journal of immunology (Baltimore, Md. : 1950)·1988
Same author

Serotherapy of cancer: cellular changes in primary rat mammary carcinomas after infusion of syngeneic sera absorbed with protein A-Sepharose.

International journal of cancer·1988
Same journal

Clinical Experience with ALG.

Behring Institute Mitteilungen·2010
Same journal

Production of a Standardized Anti-Lymphocyte Globulin.

Behring Institute Mitteilungen·2010
Same journal

Immunosuppression and Neoplasia.

Behring Institute Mitteilungen·2010
Same journal

Molecular and Immunological Aspects of Host-Parasite Interactions. Symposium proceedings. Wurzburg, Germany, June 6-8, 1996.

Behring Institute Mitteilungen·1997
Same journal

The galactose-inhibitable surface lectin of Entamoeba histolytica, a possible candidate for a subunit vaccine to prevent amoebiasis.

Behring Institute Mitteilungen·1997
Same journal

Plasmodium vivax: epitope mapping of monoclonal antibodies against the N-terminal region of the merozoite surface protein 1.

Behring Institute Mitteilungen·1997
See all related articles

Antibody configuration, influenced by epitope distribution and density, is crucial for activating the classical complement pathway. This confirms C1 binding is necessary but not sufficient for complement activation.

Area of Science:

  • Immunology
  • Complement System
  • Structural Biology

Background:

  • The classical complement pathway is initiated by the binding and activation of the C1 complex.
  • Activation requires specific antibody classes and configurations to convert C1s zymogen to active C1s.
  • Active C1s enzymatically cleaves C4 and C2, key steps in complement cascade.

Purpose of the Study:

  • To investigate the role of epitope distribution and density in controlling antibody configuration.
  • To determine how antibody configuration influences the activation of bound C1.
  • To provide evidence supporting the hypothesis that epitope characteristics are critical for complement activation.

Main Methods:

  • Analysis of immune complex formation and antibody structure.

Related Experiment Videos

  • Assays to measure C1 binding to immune complexes.
  • Functional assays to assess C1 activation and subsequent complement component cleavage.

    • Main Results:

    • Evidence indicates epitope distribution and density significantly control antibody configuration.
    • Specific antibody configurations are necessary for effective C1 activation.
    • Confirms that C1 binding to immune complexes is a prerequisite but not sufficient for activation.

    Conclusions:

    • Epitope characteristics are a major determinant of antibody conformation relevant to complement activation.
    • Antibody configuration, dictated by epitope presentation, is a critical checkpoint for initiating the classical complement pathway.
    • Understanding these structural requirements advances knowledge of immune complex-mediated complement function.